[go: up one dir, main page]

Satoh et al., 1993 - Google Patents

Bladder carcinoma producing granulocyte colony-stimulating factor: a case report

Satoh et al., 1993

Document ID
4388713923707578522
Author
Satoh H
Abe Y
Katoh Y
Komine Y
Nakamura M
Tamaoki N
Publication year
Publication venue
The Journal of urology

External Links

Snippet

A 67-year-old man with squamous cell bladder carcinoma showed remarkable leukocytosis (maximum 50,300 per μl.) for 4 months while the neoplasm recurred and metastasis progressed. The patient died of systemic metastasis within 9 months after cystectomy …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Similar Documents

Publication Publication Date Title
Wada et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
Satoh et al. Bladder carcinoma producing granulocyte colony-stimulating factor: a case report
Bian et al. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
Doi et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice
Thong-Ngam et al. Diagnostic role of serum interleukin-18 in gastric cancer patients
Lamarthee et al. Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10
Jung et al. Mucinous tubular and spindle cell carcinoma of the kidney with neuroendocrine differentiation: report of two cases
Ding et al. The therapeutic potential of a C‐X‐C chemokine receptor type 4 (CXCR‐4) antagonist on hypertrophic scarring in vivo
Ozcan et al. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications
Silva et al. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense
Yamamoto et al. Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma
Kasi Loknath Kumar et al. Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor–a potential neoplastic marker: a case report and review of the literature
Yazawa et al. Thyroid anaplastic carcinoma producing granulocyte-colony-stimulating factor and parathyroid hormone-related protein
Uematsu et al. Granulocyte-colony stimulating factor produced by pancreatic carcinoma
Horii et al. Granulocyte colony stimulating factor‐producing tongue carcinoma
Katoh et al. Autonomous production of granulocyte-colony stimulating factor in tumour xenografts associated with leukocytosis
Eccles et al. Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma fromchildren and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator
Loughlin et al. The relationship of lactoferrin to the anemia of renal cell carcinoma
Boo et al. Inflammatory myofibroblastic tumor of the kidney in a child: report of a case
CN120131961A (en) TRIM38 as a therapeutic target and prognostic marker for breast cancer
Susil et al. Sarcomatous change in granulosa cell tumor
Komatsuda et al. Crescentic glomerulonephritis accompanied by myeloperoxidase-antineutrophil cytoplasmic antibodies in a patient having myelodysplastic syndrome with trisomy 7
Mehrotra et al. Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ.
Yokoi et al. Intraglomerular metastasis from pancreatic cancer
Ito et al. Urinary bladder carcinoma producing granulocyte colony stimulating factor (G-CSF): a case report with immunohistochemistry